SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: geewiz who wrote (252)12/23/1998 12:01:00 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3557
 
This are good news for therapeutic angiogenesis.

FGF and VEGF are known for some time, so it is normally that they are ahead of REGN angio-factors, Ang-1 and -2.

I think that REGN is progressing with Ang-1 for cardiovascular indications and we may expect IND in 99.

Great Holidays to you.

Miljenko